Table V.

Results of Antifungal Activity Studies on Candida Species

	Inhibition zone (mm)a ± SD
Microorganisms	G1	G2	G3	G4	P	T-HCl
Candida albicans ATCC 10231	41 ± 0.5	36 ± 0.4	36 ± 0.5	35 ± 0.3	21 ± 0.4	35 ± 0.5
Candida albicans CDC-B 385	40 ± 0.4	28 ± 0.3	29 ± 0.5	28 ± 0.5	18 ± 0.3	34 ± 0.5
Candida krusei ATCC 6258	31 ± 0.7	19 ± 0.4	20 ± 0.5	18 ± 0.2	12 ± 0.2	27 ± 0.4
Candida parapsilosis ATCC 90018	59 ± 0.5	50 ± 0.7	45 ± 0.3	45 ± 0.5	37 ± 0.6	53 ± 0.8
Candida tropicalis RSSK 665	37 ± 0.3	27 ± 0.5	21 ± 0.6	20 ± 0.4	11 ± 0.5	35 ± 0.6
Candida glabrata (clinical isolate)	35 ± 0.5	18 ± 0.3	17 ± 0.4	16 ± 0.4	11 ± 0.5	33 ± 0.5
Candida keyfr (clinical isolate)	36 ± 0.5	26 ± 0.4	26 ± 0.4	24 ± 0.5	12 ± 0.3	33 ± 0.5
Candida guillermondi (clinical isolate)	45 ± 0.6	33 ± 0.7	33 ± 0.5	33 ± 0.8	15 ± 0.4	43 ± 0.7
Candida dubliniensis CD36	49 ± 0.8	38 ± 0.3	40 ± 0.8	35 ± 0.5	23 ± 0.5	43 ± 0.7

^aEach value represents the mean ± SD (n = 3)